4-chloro-N-(2-morpholin-4-ylethyl)benzamide;4-chloro-N-(2-morpholinoethyl)benzamide;71320-77-9;4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide;MLS000070549;SMR000012114;Aurorix (TN);D02561;Moclobemide (USAN);4-Chlor-N-(2-morpholinoethyl)benzamid;4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide;Aurorix;BENZAMIDE, 4-CHLORO-N-(2-(4-MORPHOLINYL)ETHYL)-;BIM-0048213.P001;HSDB 7180;Moclobemid;Moclobemida [INN-Spanish];Moclobemide;Moclobemide [USAN:BAN:INN];Moclobemidum [INN-Latin];Ro 11-1163;Ro 11-1163/000;p-Chloro-N-(2-morpholinoethyl)benzamide;BRN 0530974;4-chloro-N-(2-morpholin-4-ylethyl)benzamide;MLS000759438;Oprea1_270122;Manerix;Moclamine;Ro-11-1163;BAS 03214735;Oprea1_256739;CBMicro_048319;STK222240
4-chloro-N-(2-morpholin-4-ylethyl)benzamide